Global Rapid Diagnostic Kits Market Overview
Rapid Diagnostic Kits Market accounted for US$ 17.4 Billion in 2024 and is estimated to be US$ 55.7 Billion by 2034 and is anticipated to register a CAGR of 12.30%.
Rapid medical diagnostic kits are used for detecting or diagnosing a wide range of infections, conditions, and diseases that the person might be suffering from. Moreover, these kits offer an accurate diagnosis for diseases, such as malaria, and conditions, such as diabetes and pregnancy. The rapidly growing medical diagnostics industry and high demand for the preventive management of infectious diseases caused by viruses and bacteria, worldwide, are some of the factors contributing to the growth of the rapid diagnostic kits market.
Global Rapid Diagnostic Kits Market Dynamics
Increasing Number of Government Initiatives
Increasing number of government initiatives for the diagnosis of infectious disease incidence, along with the rising need for fast detection of diseases, which are also contributing to the increasing demand for rapid diagnostic tests, across the world. In addition to this, the growth of government initiatives, such as awareness programs and funding research studies, has influenced the healthcare industry. The government proactively invests in many of the research studies that include the diagnosis of infectious diseases. Thus, increasing government initiatives for the efficient diagnosis of infectious diseases help in driving the overall growth of the Target market.
Growing Prevalence of Disease
The growing prevalence of cardiovascular diseases, sexually transmitted diseases, diabetes, infectious diseases, hepatitis and gastrointestinal diseases is the most significant driver of the global rapid medical diagnostic kits market. In addition, this market is driven by factors such as growing patient awareness levels, constantly improving healthcare infrastructure, rising demand for home healthcare and rising prevalence of lifestyle induced disorders such as obesity. The patients suffering from chronic diseases are found to have an increased risk of developing end-stage heart failure diseases. Therefore, the early identification and management of patients with chronic diseases are found to be important, in order to decrease morbidity and mortality.
Lack of Awareness
Lack of awareness regarding newer rapid diagnostic tests coupled with the failure to eliminate the need for microscopy diagnosis might restrain the growth of the market during the given time frame.
The increase in home healthcare is giving opportunity for rapid diagnostics. This brings treatment and prevention care options to the patient’s home, thus, avoiding the long queue in hospitals. This saves the patients' time and travel costs.
Global Rapid Diagnostic Kits Market Segmentation
Rapid diagnostic kits market is segmented based on technology, application, and region.
On the basis of technology, the global rapid diagnostic kits market is segmented into flow through, solid phase, lateral flow, and agglutination assays. Based on application, the target market is classified into hospitals and clinical testing, home testing, and veterinary testing.
Regional Insights
On region the rapid diagnostic kits market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the overall market throughout the forecast period. The presence of high per capita healthcare expenditures coupled with high patient awareness levels and the high prevalence of target diseases are some of the factors accounting for its large market share. However, the presence of a large base of patients with unmet medical needs in emerging economies such as India and China will help the Asia-Pacific rapid medical diagnostic kits market grow at the fastest rate during the forecast period.
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Million & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Technology - Flow Through, Solid Phase, Lateral Flow, and Agglutination Assays By Application – Hospitals and Clinical Testing, Home Testing, and Veterinary Testing |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Rapid Diagnostic Kits market report based on technology, application, and region:
Rapid Diagnostic Kits Market, By Technology:
- Flow Through
- Solid Phase
- Lateral Flow
- Agglutination Assays
Rapid Diagnostic Kits Market, By Application:
- Hospitals and Clinical Testing
- Home Testing
- Veterinary Testing
Rapid Diagnostic Kits Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
-
- U.S.
- Canada
- Middle East & Africa
Global Rapid Diagnostic Kits Market Key Players
The key players operating the rapid diagnostic kits market includes Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Global BioDiagnostics Corporation, Atlas Link Biotech Co. Ltd, Alere, BioMérieux, Accutech LLC, Acon Laboratories Inc., and Artron Laboratories. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. For instance, in February 2020, Chinese university develops rapid test kit for coronavirus. In November 2019, Acon Laboratories announces the launch of on call extra mobile glucose monitoring system.
Global Rapid Diagnostic Kits Market Company Profile
- Roche Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abbott Laboratories
- Siemens Healthcare
- Global BioDiagnostics Corporation
- Atlas Link Biotech Co. Ltd
- Alere
- BioMérieux
- Accutech LLC
- Acon Laboratories Inc.
- Artron Laboratories
“*” marked represents similar segmentation in other categories in the respective section
Global Rapid Diagnostic Kits Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for Rapid Diagnostic Kits Strategies
- Key Questions this Study will Answer
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Technology, 2024– 2034, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2024– 2034
- Y-o-Y Growth Analysis (%), 2024– 2034
- Segment Trends
- Flow Through
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024– 2034
- Solid Phase
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024– 2034
- Lateral Flow
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024– 2034
- Agglutination Assays
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024– 2034
- Overview
- Market Segmentation, By Application, 2024– 2034, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2024– 2034
- Y-o-Y Growth Analysis (%), 2024– 2034
- Segment Trends
- Hospitals and Clinical Technology
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024– 2034
- Home Technology
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024– 2034
- Veterinary Technology
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024– 2034
- Overview
- Global Market, By Region, 2024– 2034, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2024– 2034
- Y-o-Y Growth Analysis (%), 2024– 2034
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Technology, 2024– 2034
- Market Size and Forecast (US$ Bn), By Application, 2024– 2034
- Market Rapid Diagnostic Kits and Forecast (US$ Bn), By Country, 2024– 2034
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Technology, 2024– 2034
- Market Size and Forecast (US$ Bn), By Application, 2024– 2034
- Market Rapid Diagnostic Kits and Forecast (US$ Bn), By Country, 2024– 2034
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Technology, 2024– 2034
- Market Size and Forecast (US$ Bn), By Application, 2024– 2034
- Market Rapid Diagnostic Kits and Forecast (US$ Bn), By Country, 2024– 2034
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Technology, 2024 2034
- Market Size and Forecast (US$ Bn), By Application, 2024 2034
- Market Rapid Diagnostic Kits and Forecast (US$ Bn), By Country, 2024 2034
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Technology, 2024 2034
- Market Size and Forecast (US$ Bn), By Application, 2024 2034
- Market Rapid Diagnostic Kits and Forecast (US$ Bn), By Country, 2024 2034
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Roche Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Abbott Laboratories
- Siemens Healthcare
- Global BioDiagnostics Corporation
- Atlas Link Biotech Co. Ltd
- Alere
- BioMerieux
- Accutech LLC
- Acon Laboratories Inc.
- Artron Laboratories
- Roche Diagnostics
-
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The global rapid diagnostic kits market is segmented based on technology, application, and region.
Growing prevalence of disease is the major propelling factor for the growth of the target market.
North America is expected to dominate the overall market throughout the forecast period.
Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. For instance, in February 2020, Chinese university develops rapid test kit for coronavirus. In November 2019, Acon Laboratories announces the launch of on call extra mobile glucose monitoring system.